“Expression of Glioblastoma Molecular Markers and Sensitivity to Innate Immune Peptides LL-37 and Protegrin-1 As Predictors of Chemotherapy Response”. 2026. London Journal of Medical and Health Research 26 (2): 15-25. https://journalspress.uk/index.php/LJMHR/article/view/1776.